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INNOVATION IN BIOTECHNOLOGY
Session Chair - Craig A. Nard
Speaker - Arnold Naimark

INTRODUCTION
CraigA. Nard

Good afternoon, everyone. My name is Craig Nard. I am a member of the
faculty here at the law school, and I direct the Center for Law Technology
and the Arts. It is a real treat for me to be the moderator of this panel on biotechnology, innovation, and health.
This is my first time as a participant in the conference of the CanadaUnited States Institute, and I want to thank the organizers for inviting me,
particularly my colleague Henry King who continues to do wonderful things
for the Law School and the university and served the public well ever since
his time in the 1940s. Thank you, Henry, for allowing me to participate today.
The topic of this panel biotechnology, innovation, and health, sort of biotechnology as it relates to Canadian practices and American practices, continues to be germane to discussions both in the academy and in government
and the private sector ever since biotechnology sort of took off in the late
'70s and early '80s with some very important Supreme Court decisions in this
country.
And as technology grew and legislative acts such as the Bayh-Dole Act,'
what you have now, we are talking about patenting life, innovations that deal
with life or living things, sometimes naturally occurring things, and the debate and relationship among innovation, public health, and proprietary rights
is an important one, and no easy answers but a lot of good questions.
And it is really a privilege for me to introduce our panelist, Dr. Arnold
Naimark who is really quite well qualified to help us navigate through some
of these very tricky issues. Dr. Naimark is currently Professor of Medicine
and Physiology at the University of Manitoba and Director of its Center for
the Advancement of Medicine.
He is founding chairman of the Canadian Health Research Foundation
and Canadian Biotechnology Advisory Committee.
Patent and Trademark Law Amendments Act, 35 U.S.C. § 200-12 (1980).
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It is my pleasure to welcome you, Dr. Naimark.
SPEAKER
(Dr. Naimark has submitted a paper which is published below in its entirety.)
BIOTECHNOLOGY, INNOVATION AND HEALTH
Dr. Arnold Naimark*

INTRODUCTION
Innovation has been a hot topic in Canada in recent years. Pundits, policy
wonks, captains of industry, politicians and academics have come to espouse
a strong culture of innovation as Canada's best hope for long-term economic
growth. Although Canada's economy is doing relatively well just now, we
recognize that much of our current prosperity relies on export of commodities and that we still have a significant distance to go to reach the productivity levels of the United States.
Beginning in the 1990's the federal government and the wealthier provinces introduced targeted and well-funded initiatives to support the academic,
research and infrastructure requirements of an "innovation agenda" with a
strong emphasis on collaborative efforts through the development of innovation clusters and networks. A significant portion of this investment has been
directed to the life sciences generally and in particular to the applications of
biotechnology in health, agriculture, aquaculture, forestry, health and the
environment - with the lion's share going to human and animal health.
The area of biotechnology attracting most of the attention are the result of
revolutionary discoveries in molecular biology and genetics - discoveries
that have produced powerful new tools to promote health and to aid in the
prevention, diagnosis and treatment of disease and disability. Knowing the
* Dr. Arnold Naimark is currently Professor of Medicine and Physiology at the University
of Manitoba and Director of its Centre for the Advancement of Medicine. He is the Founding
Chairman of the Canadian Health Services Research Foundation and of the Canadian Biotechnology Advisory Committee, Chairman of the Science Advisory Board of Health Canada and
Chairman of Genome Prairie. Dr. Naimark serves on the Council of the Canadian Institute for
Advanced Research, on the National Statistics Council of Canada, and as a Director of the
Robarts Research Institute. He also serves as director of or consultant to several voluntary,
public and private sector organizations.

